ATE396175T1 - Zusammensetzung enthaltend mx-dtpa und dessen verwendung zur herstellung von radiomarkiertem mx-dtpa - Google Patents

Zusammensetzung enthaltend mx-dtpa und dessen verwendung zur herstellung von radiomarkiertem mx-dtpa

Info

Publication number: ATE396175T1
Authority: AT; Austria
Prior art keywords: dtpa; radiom; labled; producing; composition containing
Prior art date: 1999-03-03

Application number

AT00913703T

Other languages

English (en)

Inventor

Paul Chinn

Albert Gyorkos

Michael Labarre

Steve Ruhl

Thomas Ryskamp

Original Assignee

Biogen Idec Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-03

Filing date

2000-03-02

Publication date

2008-06-15

2000-03-02 Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc

2008-06-15 Application granted granted Critical

2008-06-15 Publication of ATE396175T1 publication Critical patent/ATE396175T1/de

Links

FZDFGHZZPBUTGP-UHFFFAOYSA-N 2-[[2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(N(CC(O)=O)CC(O)=O)CC1=CC=C(N=C=S)C=C1 FZDFGHZZPBUTGP-UHFFFAOYSA-N 0.000 title 2
230000015572 biosynthetic process Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
238000003786 synthesis reaction Methods 0.000 abstract 2
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical class OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 abstract 1
239000013522 chelant Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
238000005342 ion exchange Methods 0.000 abstract 1
238000000163 radioactive labelling Methods 0.000 abstract 1
238000000926 separation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Catalysts (AREA)
Cosmetics (AREA)
Detergent Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT00913703T 1999-03-03 2000-03-02 Zusammensetzung enthaltend mx-dtpa und dessen verwendung zur herstellung von radiomarkiertem mx-dtpa ATE396175T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/261,207 US6207858B1 (en)	1999-03-03	1999-03-03	Regioselective synthesis of DTPA derivatives

Publications (1)

Publication Number	Publication Date
ATE396175T1 true ATE396175T1 (de)	2008-06-15

Family

ID=22992340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00913703T ATE396175T1 (de)	1999-03-03	2000-03-02	Zusammensetzung enthaltend mx-dtpa und dessen verwendung zur herstellung von radiomarkiertem mx-dtpa

Country Status (19)

Country	Link
US (1)	US6207858B1 (de)
EP (1)	EP1157004B1 (de)
JP (2)	JP5357368B2 (de)
CN (2)	CN1342141A (de)
AT (1)	ATE396175T1 (de)
AU (1)	AU778816B2 (de)
BR (1)	BR0008693A (de)
CA (1)	CA2364960C (de)
CY (1)	CY1108271T1 (de)
DE (1)	DE60038953D1 (de)
DK (1)	DK1157004T3 (de)
ES (1)	ES2304944T3 (de)
MX (1)	MXPA01008784A (de)
NO (1)	NO328049B1 (de)
PL (1)	PL211510B1 (de)
PT (1)	PT1157004E (de)
RU (1)	RU2312852C2 (de)
WO (1)	WO2000051976A1 (de)
ZA (1)	ZA200106750B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207858B1 (en) *	1999-03-03	2001-03-27	Idec Pharmaceuticals Corporation	Regioselective synthesis of DTPA derivatives
RU2211721C2 (ru) *	2001-07-06	2003-09-10	Производственное объединение "МАЯК"	Способ хроматографического разделения редкоземельных и трансплутониевых элементов
TWI240632B (en) *	2001-07-30	2005-10-01	Epix Medical Inc	Purified peptides for peptide-based multimeric targeted contrast agents
US7563433B2 (en) *	2007-01-11	2009-07-21	Immunomedics, Inc.	Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en)	2007-01-11	2011-08-09	Immunomedics, Inc.	Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7597876B2 (en) *	2007-01-11	2009-10-06	Immunomedics, Inc.	Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
DE10305462A1 (de) *	2003-02-04	2004-08-12	Schering Ag	Konjugate enantiomerenreiner (4S,8S)- und (4R,8R)-4-p-Benzyl-8-methyl-3,6,9-triaza-3N, 6N, 9N-tricarboxymethyl-1,11-undecandisäure mit Biomolekülen, Verfahren zu deren Herstellung und Verwendung zur Herstellung
DE10305463A1 (de) *	2003-02-04	2004-08-12	Schering Ag	Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel
US20040208828A1 (en) *	2003-02-04	2004-10-21	Lutz Lehmann	Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic acid and derivatives thereof, process for their production and use for the production of pharmaceutical agents
EP1740617B1 (de) *	2004-04-23	2013-10-16	BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten	Verfahren zur behandlung von erkrankungen, die mit t-zellen im zusammenhang stehen, durch eliminierung von icos-positiven zellen in vivo
US7842279B2 (en) *	2005-08-31	2010-11-30	Immunomedics, Inc.	F-18 peptides for pre targeted positron emission tomography imaging
WO2008070384A2 (en) *	2006-11-06	2008-06-12	Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Method of preparing macromolecular contrast agents and uses thereof
US8153100B2 (en) *	2007-01-11	2012-04-10	Immunomedics, Inc.	Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US8709382B2 (en)	2007-01-11	2014-04-29	Immunomedics, Inc.	Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US8889100B2 (en)	2007-01-11	2014-11-18	Immunomedics, Inc.	Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US8545809B2 (en)	2007-01-11	2013-10-01	Immunomedics, Inc.	Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
US8398956B2 (en)	2007-01-11	2013-03-19	Immunomedics, Inc.	In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
US10189803B2 (en)	2008-02-22	2019-01-29	Illinois Institute Of Technology	Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
US10556873B2 (en)	2008-02-22	2020-02-11	Illinois Institute Of Technology	Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
US9446995B2 (en)	2012-05-21	2016-09-20	Illinois Institute Of Technology	Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
WO2010011367A2 (en) *	2008-02-22	2010-01-28	Illinois Institute Of Technology	Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
AU2010326004B2 (en) *	2009-12-04	2016-04-21	Immunomedics, Inc.	Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
CN102773078A (zh) *	2012-07-16	2012-11-14	武汉纺织大学	同时吸附阳、阴离子的固体配位萃取剂及其制备和应用
WO2015051362A1 (en)	2013-10-04	2015-04-09	Illinois Institute Of Technology	Multifunctional chelators, complexes, and compositions thereof, and methods of using same
CN103601648B (zh) *	2013-11-19	2015-03-25	宜兴市丰泽化工有限公司	一种dtpa五钠盐的脱盐提纯方法
EP4600368A1 (de)	2024-02-09	2025-08-13	Adisseo France S.A.S.	Verfahren zur enzymatischen herstellung einer amidverbindung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5099069A (en) *	1986-09-05	1992-03-24	Gansow Otto A	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
EP0529645B1 (de) *	1986-09-05	1996-10-23	GANSOW, Otto A.	Verfahren zur Herstellung hauptkettenpolysubstituierter Chelate
US5246692A (en) *	1986-09-05	1993-09-21	The United States Of America As Represented By The Secretary Of Health And Human Services	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) *	1986-09-05	1989-05-16	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
DK0429644T3 (da) *	1989-05-26	1996-01-22	Ramaswamy Subramanian	Chelat-dannende midler til binding af metalioner til proteiner
US5124471A (en) *	1990-03-26	1992-06-23	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Bifunctional dtpa-type ligand
DK0752248T3 (da) *	1992-11-13	2000-11-13	Idec Pharma Corp	Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
KR970700698A (ko) *	1994-01-07	1997-02-12	에프. 지. 엠. 헤르만스; 이. 에이취. 리링크	폴리아미노카르복실레이트 킬레이트제(new polyaminocarboxylate chelators)
US20020102208A1 (en) *	1999-03-01	2002-08-01	Paul Chinn	Radiolabeling kit and binding assay
US6207858B1 (en) *	1999-03-03	2001-03-27	Idec Pharmaceuticals Corporation	Regioselective synthesis of DTPA derivatives

1999
- 1999-03-03 US US09/261,207 patent/US6207858B1/en not_active Expired - Fee Related
2000
- 2000-03-02 DK DK00913703T patent/DK1157004T3/da active
- 2000-03-02 JP JP2000602204A patent/JP5357368B2/ja not_active Expired - Lifetime
- 2000-03-02 CA CA2364960A patent/CA2364960C/en not_active Expired - Lifetime
- 2000-03-02 CN CN00804499.6A patent/CN1342141A/zh active Pending
- 2000-03-02 PL PL350903A patent/PL211510B1/pl unknown
- 2000-03-02 AU AU35099/00A patent/AU778816B2/en not_active Expired
- 2000-03-02 WO PCT/US2000/005433 patent/WO2000051976A1/en not_active Ceased
- 2000-03-02 RU RU2001126722/04A patent/RU2312852C2/ru active
- 2000-03-02 EP EP00913703A patent/EP1157004B1/de not_active Expired - Lifetime
- 2000-03-02 PT PT00913703T patent/PT1157004E/pt unknown
- 2000-03-02 AT AT00913703T patent/ATE396175T1/de active
- 2000-03-02 DE DE60038953T patent/DE60038953D1/de not_active Expired - Lifetime
- 2000-03-02 CN CN200410031255.0A patent/CN1290830C/zh not_active Expired - Lifetime
- 2000-03-02 MX MXPA01008784A patent/MXPA01008784A/es active IP Right Grant
- 2000-03-02 BR BR0008693-2A patent/BR0008693A/pt not_active Application Discontinuation
- 2000-03-02 ES ES00913703T patent/ES2304944T3/es not_active Expired - Lifetime
2001
- 2001-08-15 ZA ZA200106750A patent/ZA200106750B/en unknown
- 2001-08-29 NO NO20014194A patent/NO328049B1/no not_active IP Right Cessation
2008
- 2008-08-19 CY CY20081100882T patent/CY1108271T1/el unknown
2013
- 2013-03-27 JP JP2013066359A patent/JP2013144705A/ja active Pending

Also Published As

Publication number	Publication date
JP5357368B2 (ja)	2013-12-04
JP2002538137A (ja)	2002-11-12
JP2013144705A (ja)	2013-07-25
ES2304944T3 (es)	2008-11-01
CN1548419A (zh)	2004-11-24
WO2000051976A1 (en)	2000-09-08
EP1157004A1 (de)	2001-11-28
CN1342141A (zh)	2002-03-27
AU3509900A (en)	2000-09-21
NO328049B1 (no)	2009-11-16
NO20014194D0 (no)	2001-08-29
MXPA01008784A (es)	2002-04-24
PT1157004E (pt)	2008-08-29
PL350903A1 (en)	2003-02-10
US6207858B1 (en)	2001-03-27
AU778816B2 (en)	2004-12-23
CN1290830C (zh)	2006-12-20
ZA200106750B (en)	2002-11-15
EP1157004B1 (de)	2008-05-21
CY1108271T1 (el)	2014-02-12
DK1157004T3 (da)	2008-09-15
CA2364960C (en)	2010-05-11
NO20014194L (no)	2001-10-26
PL211510B1 (pl)	2012-05-31
BR0008693A (pt)	2001-12-26
DE60038953D1 (de)	2008-07-03
RU2312852C2 (ru)	2007-12-20
HK1069380A1 (en)	2005-05-20
CA2364960A1 (en)	2000-09-08

Legal Events

Date

Code

Title

Description

2009-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1157004

Country of ref document: EP

Publication	Publication Date	Title
ATE396175T1 (de)	2008-06-15	Zusammensetzung enthaltend mx-dtpa und dessen verwendung zur herstellung von radiomarkiertem mx-dtpa
NO20031687D0 (no)	2003-04-11	Veksthormonsekretagoger
EA200001102A1 (ru)	2001-04-23	Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
MXPA02011370A (es)	2003-06-06	Iminoazinas substituidas.
TW200500339A (en)	2005-01-01	Pyrrolidine derivatives, and process for the preparation
EA200600621A1 (ru)	2006-10-27	Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ZA200404752B (en)	2005-04-26	6-aminomorphinane derivatives method for the production and use thereof
DE69918465D1 (de)	2004-08-05	Sulfonamidhydroxamate
HRP20080057T3 (en)	2008-02-29	9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
NO20016151L (no)	2001-12-17	Fremstilling av substituerte piperidin-4-oner
DE60235365D1 (de)	2010-04-01	Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
TR200503401T1 (tr)	2008-03-21	Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
TW200633977A (en)	2006-10-01	Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
TW200745039A (en)	2007-12-16	Isotopically substituted pantoprazole
ATE445617T1 (de)	2009-10-15	Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel
TW200621703A (en)	2006-07-01	Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE60306636D1 (de)	2006-08-17	Wachstumhormonsekretionsförderer
DE60329721D1 (de)	2009-11-26	Regiospezifische synthese von nikotinderivaten
DK1250335T3 (da)	2005-11-14	Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
WO2004096828A3 (fr)	2004-12-29	Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
ID27656A (id)	2001-04-19	Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
ATE252566T1 (de)	2003-11-15	Herstellung von 2-(2-arylmorpholin-2- yl)ethanolderivaten und zwischenprodukte
DK1235832T3 (da)	2004-03-22	Precursorer for vitamin D, fremgangsmåde til fremstilling heraf og mellemforbindelser
SG145573A1 (en)	2008-09-29	Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
MXPA05009153A (es)	2005-10-20	Proceso para preparar 2-metilpirrolidina y enantiomeros especificos de la misma.